Regev, D.; Etzion, S.; Haddad, H.; Gopas, J.; Goldbart, A.
Obstructive Sleep Apnea Syndrome In Vitro Model: Controlled Intermittent Hypoxia Stimulation of Human Stem Cells-Derived Cardiomyocytes. Int. J. Mol. Sci. 2022, 23, 10272.
https://doi.org/10.3390/ijms231810272
AMA Style
Regev D, Etzion S, Haddad H, Gopas J, Goldbart A.
Obstructive Sleep Apnea Syndrome In Vitro Model: Controlled Intermittent Hypoxia Stimulation of Human Stem Cells-Derived Cardiomyocytes. International Journal of Molecular Sciences. 2022; 23(18):10272.
https://doi.org/10.3390/ijms231810272
Chicago/Turabian Style
Regev, Danielle, Sharon Etzion, Hen Haddad, Jacob Gopas, and Aviv Goldbart.
2022. "Obstructive Sleep Apnea Syndrome In Vitro Model: Controlled Intermittent Hypoxia Stimulation of Human Stem Cells-Derived Cardiomyocytes" International Journal of Molecular Sciences 23, no. 18: 10272.
https://doi.org/10.3390/ijms231810272
APA Style
Regev, D., Etzion, S., Haddad, H., Gopas, J., & Goldbart, A.
(2022). Obstructive Sleep Apnea Syndrome In Vitro Model: Controlled Intermittent Hypoxia Stimulation of Human Stem Cells-Derived Cardiomyocytes. International Journal of Molecular Sciences, 23(18), 10272.
https://doi.org/10.3390/ijms231810272